Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 413
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07312786 | Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors | ||
| NCT01089764 | Couplelinks.ca - An Online Intervention for Couples Affected by Breast Cancer | ||
| NCT07297667 | GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours | ||
| NCT01351116 | A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy | ||
| NCT06205485 | Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer | ||
| NCT03266900 | A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival | ||
| NCT01658930 | Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer | ||
| NCT00770185 | Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer | ||
| NCT07152821 | Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma | ||
| NCT03938987 | Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) | ||
| NCT01248585 | Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases | ||
| NCT03944798 | Surveillance AFter Extremity Tumor surgerY | ||
| NCT01783197 | Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC | ||
| NCT00078949 | Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | ||
| NCT00115713 | Effects of Aerobic Exercise Versus Weight Training in Breast Cancer Survivors During Chemotherapy | ||
| NCT03258554 | Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin | ||
| NCT06405542 | Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN) | ||
| NCT00499174 | Observation or Radical Treatment in Patients With Prostate Cancer | ||
| NCT00795340 | Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT05863910 | Real World Evidence on the Use of Medical Cannabis in Pediatrics | ||
| NCT00352079 | BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer | ||
| NCT02446405 | Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer | ||
| NCT06623461 | LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma | ||
| NCT03097445 | Long-term Effectiveness of Mailed Nicotine Replacement Therapy: A 5-year Follow-up | ||
| NCT05574426 | Efficacy of Movement Breaks in Real-World Settings | ||
| NCT05470010 | Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors | ||
| NCT00225927 | Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers | ||
| NCT00658593 | Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | ||
| NCT02343718 | Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours | ||
| NCT01526135 | Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | ||
| NCT01847976 | Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer | ||
| NCT02954289 | Cooking Class Intervention Project for Men With Prostate Cancer and Their Partners | ||
| NCT05515354 | Smoking Cessation and Menstrual Cycle Phase | ||
| NCT00031668 | Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation | ||
| NCT01354171 | Active Surveillance Magnetic Resonance Imaging Study | ||
| NCT03748550 | Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2) | ||
| NCT00371553 | Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer | ||
| NCT02649686 | Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab | ||
| NCT00275353 | Effectiveness of an Individualized Symptom Education Program (ISEP) | ||
| NCT01815476 | The Prone Breast Radiation Therapy Trial | ||
| NCT00017004 | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | ||
| NCT00010179 | Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer | ||
| NCT01389739 | Intervention to Improve Continuity of Care in Lung Cancer Patients | ||
| NCT00064194 | Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia | ||
| NCT00169845 | Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients | ||
| NCT04940507 | BRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) Trial | ||
| NCT05605509 | RP-6306 in Patients With Advanced Cancer | ||
| NCT03488693 | Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer | ||
| NCT02058615 | Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast Cancer | ||
| NCT04161248 | Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma |
